XML 14 R33.htm IDEA: XBRL DOCUMENT v3.3.0.814
STOCK INCENTIVE PLANS (Details) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended
Sep. 25, 2015
Dec. 31, 2014
Stock Options [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Vesting period 3 years  
Options [Roll Forward]    
Options outstanding at beginning of period (in shares) 6,000  
Granted (in shares) 0  
Exercised (in shares) 0  
Expired (in shares) 6,000  
Cancelled (in shares) 0  
Options outstanding at Ending of period (in shares) 0  
Vested and Exercisable at Ending of period (in shares) 0  
Weighted Average Exercise Price [Abstract]    
Options outstanding at beginning of period (in dollars per share) $ 3.69  
Granted (in dollars per share) 0  
Exercised (in dollars per share) 0  
Expired (in dollars per share) 3.69  
Cancelled (in dollars per share) 0  
Options outstanding at Ending of period (in dollars per share) 0  
Vested and Exercisable at Ending of period (in dollars per share) $ 0  
Weighted Average Remaining Contractual Life [Abstract]    
Outstanding at end of period 0 years  
Vested and Exercisable at end of period 0 years  
Aggregate Intrinsic Value [Abstract]    
Aggregate Intrinsic Value, Outstanding at end of period $ 0  
Aggregate Intrinsic Value, Vested and Exercisable at end of period $ 0  
Stock Options [Member] | Minimum [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Exercisable period 12 months  
Stock Options [Member] | Maximum [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Exercisable period 10 years  
Stock Appreciation Rights (SARs) [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Vesting period 3 years  
Expiration period 10 years  
Minimum percentage of cumulative number of vested stock appreciation rights held by an employee 50.00%  
Summary of SARs activity under applicable plans [Roll Forward]    
Non-Vested at Beginning of period (in shares) 0  
Granted (in shares) 4,000  
Vested (in shares) (4,000)  
Cancelled (in shares) 0  
Non-Vested at Ending of period (in shares) 0  
Total Outstanding at end of period (in shares) 38,000  
Aggregate liability related to SARs $ 122 $ 47